Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Aug 5, 2020, after the close
10-Q filed Aug 6, 2020, 37 days after period end · 0001564590-20-036993
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $110.10M | $83.21M | $57.06M | $30.48M |
| Net Income | -$42.14M | -$54.94M | -$63.27M | -$67.44M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.27 |
| -$0.38 |
| -$0.51 |
| -$0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
